The Effect of Escitalopram on the Pharmacokinetics and Pharmacodynamics of Tramadol in Healthy Subjects.

Trial Profile

The Effect of Escitalopram on the Pharmacokinetics and Pharmacodynamics of Tramadol in Healthy Subjects.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2012

At a glance

  • Drugs Escitalopram (Primary) ; Tramadol (Primary)
  • Indications Affective disorders; Anxiety disorders; Depressive disorders; Mood disorders; Pain
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 01 Dec 2009 Results reported in Clinical Pharmacology and Therapeutics.
    • 09 Sep 2008 Actual patient number (15) added as reported by ClinicalTrials.gov.
    • 09 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top